By meticulously selecting suitable candidates for beta cell transplantation based on a comprehensive analysis of their diabetes profile, encompassing genetic factors, insulin responsiveness, and other individual parameters, healthcare providers can provide highly personalized therapeutic options. This evidence concerns the gene INS and diabetes mellitus.